ZaluvidaInnovationSeptember2016 |
Introduction
Zaluvida is inviting companies, entrepreneurs, and nutrition industry visionaries to apply to present their product ideas at a 1 1/2 day event in September 2016 hosted by Zaluvida in Berlin, Germany, and managed by Zaluvida and Nutrition Capital Network.
The application deadline is September 10, 2016, and some of the finalists will be invited by August 31, 2016, so any interested applicants should submit their information as soon as possible or inform NCN of their intent to do so by email.
Zaluvida is a global investment holding company with a passion for innovation and an investment strategy that focuses on small to medium sized high-potential companies across the life sciences value chain with a focus on natural therapies. Zaluvida is privately owned, without financial investors and driven by purpose not short-term gains with offices in Kuala Lumpur, Malaysia and Berlin, Germany.
The current investment portfolio includes: InQpharm, Neem Biotech, Analyze & Realize and Prosanita. Through our investee companies, Zaluvida Holdings is involved in all phases of value creation in the life-science and nutraceutical industry, from early discovery and compound research to conducting pre-clinical and clinical studies leading to patentable bioactive molecules, to developing natural safe therapeutic, nutraceutical and lifestyle products. Zaluvida looks to invest in and partner with small to medium sized high-potential companies across the life sciences and nutraceutical value chain, with a focus on natural compounds and products
Zaluvida's Selection Criteria:
- Ingredients, products or technologies
- Strategic fit with Zaluvida’s health focus areas
- Strong market potential and unmet need
- Novel or unique or clear differentiation from market products/competitors
- Strong communicable benefits
- Patent protection preferred, and/or exclusive access
- Proof of concept data support for efficacy
- Basic data available for indication of safety
Areas of interest include:
- Consumer health
Natural or naturally derived compounds for:
- Weight management
- Immune health
- Heart health
- Oral health (e.g., halitosis, desensitization, remineralisation, restoration of normal flora, whitening)
- Revitalisation (healthy nutrition for cellular functions and energy production)
- Detoxification (removal of waste and toxins and regeneration of bodily functions)
- Sleep improvement
- Brain health (improving cognitive functions such as alertness and memory)
- Joint health for improved mobility
- Animal health (Natural or naturally derived compounds for livestock animals, particularly antiinfections)
- Antimicrobial for rare diseases or resistant microbes
- Consumer health – wound care application
- Orphan drug for rare diseases, e.g., cystic fibrosis
- Compounds for tree diseases
- Formulation or delivery technologies
Other innovative ingredients/technologies beside the key target areas above may also be considered, e.g., portable and smart wearable devices for healthcare.
The current investment portfolio includes: InQpharm, Neem Biotech, Analyze & Realize and Prosanita. Through our investee companies, Zaluvida Holdings is involved in all phases of value creation in the life-science and nutraceutical industry, from early discovery and compound research to conducting pre-clinical and clinical studies leading to patentable bioactive molecules, to developing natural safe therapeutic, nutraceutical and lifestyle products. Zaluvida looks to invest in and partner with small to medium sized high-potential companies across the life sciences and nutraceutical value chain, with a focus on natural compounds and products
Zaluvida's Selection Criteria:
- Ingredients, products or technologies
- Strategic fit with Zaluvida’s health focus areas
- Strong market potential and unmet need
- Novel or unique or clear differentiation from market products/competitors
- Strong communicable benefits
- Patent protection preferred, and/or exclusive access
- Proof of concept data support for efficacy
- Basic data available for indication of safety
Areas of interest include:
- Consumer health
Natural or naturally derived compounds for:
- Weight management
- Immune health
- Heart health
- Oral health (e.g., halitosis, desensitization, remineralisation, restoration of normal flora, whitening)
- Revitalisation (healthy nutrition for cellular functions and energy production)
- Detoxification (removal of waste and toxins and regeneration of bodily functions)
- Sleep improvement
- Brain health (improving cognitive functions such as alertness and memory)
- Joint health for improved mobility
- Animal health (Natural or naturally derived compounds for livestock animals, particularly antiinfections)
- Antimicrobial for rare diseases or resistant microbes
- Consumer health – wound care application
- Orphan drug for rare diseases, e.g., cystic fibrosis
- Compounds for tree diseases
- Formulation or delivery technologies
Other innovative ingredients/technologies beside the key target areas above may also be considered, e.g., portable and smart wearable devices for healthcare.